Literature DB >> 7466743

Evidence against vitamin K deficiency in normal neonates.

R G Malia, F E Preston, V E Mitchell.   

Abstract

Umbilical cord plasmas from 24 normal full-term neonates were studied. We confirmed the prolonged prothrombin time and low levels of Vitamin K dependent clotting factors previously described (1), but using a number of recently developed immunological and coagulation techniques we could find no evidence of vitamin K deficiency. We conclude that the decreased levels of vitamin K dependent clotting factors of normal neonates are the result of decreased synthesis by the immature liver and that it is questionable whether vitamin K prophylaxis is necessary for these infants.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7466743

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  VITAMIN K DEFICIENCY HEMORRHAGIC DISEASE OF NEWBORN AND PRESENT CONTROVERSIES.

Authors:  Tsraghu Raman
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Care of the newborn in perinatal units in New Brunswick.

Authors:  K K Malhotra
Journal:  CMAJ       Date:  1986-05-01       Impact factor: 8.262

3.  The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin.

Authors:  I A Choonara; R G Malia; B P Haynes; C R Hay; S Cholerton; A M Breckenridge; F E Preston; B K Park
Journal:  Br J Clin Pharmacol       Date:  1988-01       Impact factor: 4.335

4.  Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins.

Authors:  B K Park; I A Choonara; B P Haynes; A M Breckenridge; R G Malia; F E Preston
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

5.  Resurgence of hemorrhagic disease of the newborn: a report of three cases.

Authors:  B A Behrmann; W K Chan; N N Finer
Journal:  CMAJ       Date:  1985-11-01       Impact factor: 8.262

6.  Vitamin K in the newborn: influence of nutritional factors on acarboxy-prothrombin detectability and factor II and VII clotting activity.

Authors:  R von Kries; A Becker; U Göbel
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

Review 7.  The use of vitamin K in the perinatal period. Fetus and Newborn Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1988-07-15       Impact factor: 8.262

8.  Vitamin K and Thrombotest values in full term infants.

Authors:  D Garrow; M Chisholm; M Radford
Journal:  Arch Dis Child       Date:  1986-04       Impact factor: 3.791

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.